Neonatal Metabolic Screening (Newborn Screening Programs)

What Is Newborn Screening?

Newborn screening (NBS) is a state-mandated public health program that tests newborns for certain serious but treatable conditions before symptoms appear. Early identification allows treatment to begin quickly, often preventing permanent disability or death. Every US state runs its own program, so the exact panel of conditions tested varies by state. The federal advisory body that guides states on which conditions to include is the Advisory Committee on Heritable Disorders in Newborns and Children (ACHDNC), which maintains a Recommended Uniform Screening Panel (RUSP). As a phlebotomy technician, you will not interpret results, but you play a critical role in collecting a quality specimen at the right time.

Types of Conditions Screened

Newborn screening panels typically include conditions in several categories:

• Metabolic disorders — such as phenylketonuria (PKU), maple syrup urine disease (MSUD), and medium-chain acyl-CoA dehydrogenase (MCAD) deficiency. These involve the body's inability to process certain amino acids or fatty acids correctly.
• Endocrine disorders — such as congenital hypothyroidism and congenital adrenal hyperplasia (CAH).
• Hemoglobin disorders — such as sickle cell disease and other hemoglobinopathies.
• Cystic fibrosis — a serious lung and digestive disease.
• Critical congenital heart disease (CCHD) — screened by pulse oximetry rather than the blood card, but often coordinated with NBS.
• Hearing loss — also screened separately.

The blood-based portion of newborn screening uses a dried blood spot (DBS) specimen collected on a special filter paper card, sometimes called a Guthrie card after its originator.

Timing of Collection

Timing is one of the most important factors affecting result validity. Most states require the first specimen to be collected between 24 and 48 hours of life, after the newborn has received adequate feedings. Collecting too early (before 24 hours) can produce false-negative results for some metabolic conditions because certain analytes need time to accumulate to detectable levels after birth. Collecting too late delays diagnosis. If a newborn is discharged before 24 hours, a repeat specimen is generally required. Some states mandate a routine second specimen at one to two weeks of age regardless of the first result.

As the collector, you are responsible for noting the exact date and time of collection and the date and time of birth on the filter paper card. These fields are not optional.

Filter Paper Card Completion

Accurate card completion is a direct patient safety responsibility. Errors on the card can delay or invalidate results. Every demographic and clinical field must be filled in completely and legibly, including:

• Infant's full name and date of birth
• Date and time of collection
• Infant's age in hours at time of collection
• Mother's name and date of birth
• Feeding type (breast milk, formula, or parenteral nutrition — important because some analytes differ by feeding type)
• Birth weight and gestational age
• Whether the infant received a transfusion (transfusions can invalidate certain results)
• Antibiotic use (relevant for some screens)
• Facility name and contact information

Common card errors to avoid:

1. Incomplete demographic fields — Any blank field may cause the specimen to be rejected or results to be uninterpretable.

2. Layered spots — Applying multiple drops to build up a spot, or pressing the card against the heel more than once in the same circle, causes uneven blood distribution and invalid analyte concentration. Each circle should be filled with a single, continuous application.

3. Touching the card before drying — The filter paper must air-dry horizontally at room temperature for a minimum of three hours (follow your facility's protocol and card manufacturer instructions). Touching, stacking, or placing wet cards in an envelope or on a non-porous surface prevents proper drying and can cause mold, contamination, or altered analyte levels.

4. Insufficient specimen volume — Each circle must be completely saturated. A partially filled circle is unacceptable.

5. Contamination — Do not apply alcohol, lotion, powder, or other substances to the puncture site before the blood is collected; residues can interfere with results.

Transport Requirements

After drying, cards must be transported to the state laboratory promptly. Most programs require submission within 24 hours of collection, though specific deadlines vary by state. Cards are placed in the provided return envelope — not in a sealed plastic bag, which can trap moisture. They are shipped at ambient temperature unless the state program specifies otherwise. Do not refrigerate or freeze dried blood spot cards unless explicitly directed. Track submission according to your facility's chain-of-custody procedure.

Scope of Practice and Refusal Situations

If a parent or guardian refuses the newborn screen, the phlebotomist's role is limited and clearly defined:

1. Do not argue or attempt to override the refusal. That is outside your scope.

2. Document the refusal on the card or in the medical record according to facility policy.

3. Notify the nurse or supervisor immediately so the care team — nurses, physicians, and when appropriate the hospital's legal or ethics resources — can counsel the family and manage any legal reporting obligations.

State laws regarding parental refusal vary; some states allow religious or philosophical exemptions, others do not. That legal determination belongs to the care team and administration, not to you. Your job is to collect when permitted, document accurately, and escalate appropriately.

Safety Summary

• Collect at the correct time window to protect result validity and patient safety.
• Fill every field on the card — incomplete documentation is a patient safety error.
• Allow full drying before handling or packaging.
• Escalate refusals — do not manage them alone.